Molecular variability of TLS-CHOP structure shows no significant impact on the level of adipogenesis: A comparative ultrastructural and RT-PCR analysis of 14 cases of myxoid/round cell liposarcomas

Ultrastructural Pathology

Volumn 27, Issue 4, 2003, Pages 217-226

  Huang, Hsuan Ying ^a,b   Antonescu, Cristina R ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adipogenesis; EWS CHOP; Glycogen; RT PCR; TLS CHOP; Vimentin

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOGEN; HYBRID PROTEIN; VIMENTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CELL MATURATION; CELL TYPE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EWS CHOP FUSION GENE; FEMALE; FUSION GENE; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LIPOBLAST; LIPOGENESIS; MALE; MESENCHYME; MITOCHONDRION; MOLECULAR DYNAMICS; MYXOSARCOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROUGH ENDOPLASMIC RETICULUM; ROUND CELL; SOFT TISSUE METASTASIS; TISSUE SECTION; TLS CHOP FUSION GENE; TRANSITIONAL CELL; TUMOR CELL; TUMOR RECURRENCE;

ADIPOCYTES; ADOLESCENT; ADULT; CCAAT-ENHANCER-BINDING PROTEINS; FEMALE; HUMANS; LIPOSARCOMA, MYXOID; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; RNA-BINDING PROTEIN EWS; RNA-BINDING PROTEIN FUS; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTOR CHOP;

EID: 0041334078     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.1080/01913120309917     Document Type: Article

References (22)

1. Mentzel T, Fletcher CD. Lipomatous tumours of soft tissues: an update. Virchows Arch. 1995;427:353-363.
2. Antonescu CR, Tschernyavsky SJ, Decuseara R, et al. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res. 2001;7:3977-3987.
3. Antonescu CR, Elahi A, Humphrey M, et al. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas. J Mol Diagn. 2000;2:132-138.
4. Knight JC, Renwick PJ, Cin PD, Van den Berghe H, Fletcher CD. Translocation t(12;16) (q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res. 1995;55:24-27.
5. Kuroda M, Ishida T, Horiuchi H, et al. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. Am J Pathol. 1995;147:1221-1227.
6. Panagopoulos I, Mandahl N, Ron D, et al. Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. Cancer Res. 1994;54:6500-6503.
7. Panagopoulos I, Mertens F, Isaksson M, Mandahl N. A novel FUS/CHOP chimera in myxoid liposarcoma. Biochem Biophys Res Commun. 2000;279:838-845.
8. Dal Cin P, Sciot R, Panagopoulos I, et al. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features. J Pathol. 1997;182:437-441.
9. Panagopoulos I, Hoglund M, Mertens F, mandahl N, Mitelman F, Aman P. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene. 1996;12:489-494.
10. Adelmant G, Gilbert JD, Freytag SO. Human translocation liposarcoma-CCAAT/enhancer binding protein (C/EBP) homologous protein (TLS-CHOP) oncoprotein prevents adipocyte differentiation by directly interfering with C/EBPbeta function. J Biol Chem. 1998;273:15,574-15,581.
11. Tang QQ, Lane MD. Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding protein-beta during adipogenesis. Proc Natl Acad Sci USA. 2000;97:12,446-12,450.
12. Lagace R, Jacob S, Seemayer TA. Myxoid liposarcoma. An electronmicroscopic study: biological and histogenetic considerations. Virchows Arch A Pathol. Anat Histol. 1979;384:159-172.
13. Antonescu CR, Elahi A, Healey JH, et al. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements. Clin Cancer Res. 2000;6:2788-2793.
14. Kuroda M, Ishida T, Takanashi M, Satoh M, Machinami R, Watanable T. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein. Am J Pathol. 1997;151:735-744.
15. Batchvarova N, Wang XZ, Ron D. Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd 153). EMBO J. 1995;14:4654-4661.
16. Franke WW, Hergt M, Grund C. Rearrangement of the vimentin cytoskeleton during adipose conversion: formation of an intermediate filament cage around lipid globules. Cell. 1987;49:131-141.
17. Wang SM, Fong TH, Hsu SY, Chien CL, Wu JC. Reorganization of a novel vimentin-associated protein in 3T3-L1 cells during adipose conversion. J Cell Biochem. 1997;67:84-91.
18. Lieber JG, Evans RM. Disruption of the vimentin intermediate filament system during adipose conversion of 3T3-L1 cells inhibits lipid droplet accumulation. J Cell Sci. 1996;109:3047-3058.
19. Tardio J, Escalona-Zapata J, Diez-Nau DD. The behaviour of liposarcoma in tissue culture: a specific growth pattern. J Pathod. 1993;170:451-456.
20. Rossouw DJ, Cinti S, Dickersin GR. Liposarcoma. An ultrastructural study of 15 cases. Am J Clin Pathol. 1986;85:649-667.
21. Fu YS, parker FG, Kaye GI, Lattes R. Ultrastructure of benign and malignant adipose tissue tumors. Pathol. Annu. 1980;15:67-89.
22. Vuzevski VD, van der Heul RO. Comparative ultrastructure of soft-tissue myxoid tumors. Ultrastruct Pathol. 1988;12:87-105.